Finance

Beta
Lists
7733:TYO
Olympus Corp
Â¥1,647.50
-3.03%
(-51.50) 1D
Jul 1, 11:29:30 AM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 7733...
Open
Â¥1,676
High
Â¥1,686
Low
Â¥1,646
Mkt. cap
1.84T
Avg. vol.
5.12M
Volume
1.07M
P/E ratio
26.87
52-wk high
Â¥2,168
52-wk low
Â¥1,302
EPS
Â¥61
Shares outstanding
341.42M
No. of employees
28K
Open
Â¥1,676
High
Â¥1,686
Low
Â¥1,646
Mkt. cap
1.84T
Avg. vol.
5.12M
Volume
1.07M
P/E ratio
26.87
52-wk high
Â¥2,168
52-wk low
Â¥1,302
EPS
Â¥61
Shares outstanding
341.42M
No. of employees
28K
News stories
From sources across the web
Profile
Olympus Corporation is a Japanese manufacturer of optics and reprography products, headquartered in Hachioji, Tokyo. Olympus was founded on October 12, 1919 as Takachiho Seisakusho by Takeshi Yamashita, initially specializing in microscopes and thermometers, and later in imaging. In 1921, the name Olympus was registered as a trademark. In 1942, the company was renamed Takachiho Optical Industries, and in 1949 it was renamed Olympus Optical Co., Ltd. In 2003, the company adopted its current name, Olympus Corporation. Olympus holds roughly a 70 percent share of the global endoscope market, estimated to be worth approximately US$2.5 billion. As of 2025, endoscopes and related surgical technologies are now Olympus's exclusive product line. It was formerly also a maker of cameras, camera lenses and dictaphones, until it divested this part to OM Digital Solutions in 2020. It divested from its microscopy and scientific imaging division in 2023, selling it to Bain Capital for approximately $3.1 billion; the division operates as Evident Corporation. Wikipedia
About Olympus Corp
CEOYasuo Takeuchi
Employees28.1K
FoundedOct 12, 1919
Headquarters-
SectorMedical device
Last report
May 12, 2026
Fiscal period
Q4 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
295.28B / 281.71B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
206.51B
247.84B
261.04B
295.28B
Cost of goods sold
71.38B
86.54B
96.15B
102.52B
Cost of revenue
71.38B
86.54B
96.15B
102.52B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
122.19B
119.90B
125.65B
104.14B
Operating expense
118.78B
127.74B
140.86B
145.88B
Total operating expenses
190.16B
214.27B
237.01B
248.41B
Operating income
16.35B
33.56B
24.04B
46.88B
Other non operating income
-40.00M
-
-
-819.00M
EBT including unusual items
16.89B
27.90B
22.13B
27.08B
EBT excluding unusual items
16.89B
27.90B
22.13B
47.09B
Income tax expense
7.90B
7.70B
7.96B
2.26B
Effective tax rate
46.75%
27.61%
35.98%
8.36%
Other operating expenses
-3.41B
7.83B
15.21B
6.54B
Net income
8.99B
20.20B
14.17B
24.82B
Net profit margin
4.35%
8.15%
5.43%
8.40%
Earnings per share
-
-
-
-
Interest and investment income
1.48B
3.64B
356.00M
3.96B
Interest expense
-1.16B
-5.28B
-2.34B
-2.92B
Net interest expenses
329.00M
-1.64B
-1.99B
1.04B
Depreciation and amortization charges
-
-
-
35.20B
EBITDA
32.56B
50.30B
41.76B
63.42B
Gain or loss from assets sale
-
-
-
12.08B
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more